Validation of LUCIO®-Direct-ELISA kits for the detection of drugs of abuse in urine: Application to the new German driving licence re-granting guidelines
被引:19
作者:
Agius, Ronald
论文数: 0引用数: 0
h-index: 0
机构:
Lab Krone, D-32105 Bad Salzuflen, GermanyLab Krone, D-32105 Bad Salzuflen, Germany
Agius, Ronald
[1
]
Nadulski, Thomas
论文数: 0引用数: 0
h-index: 0
机构:
Lab Krone, D-32105 Bad Salzuflen, GermanyLab Krone, D-32105 Bad Salzuflen, Germany
Nadulski, Thomas
[1
]
Moore, Christine
论文数: 0引用数: 0
h-index: 0
机构:
Immunalysis Corp, Pomona, CA 91767 USALab Krone, D-32105 Bad Salzuflen, Germany
Drug screening;
Zero-tolerance cut-offs;
Driving licence re-granting guidelines;
Abstinence control;
Uncertainty of measurement;
Forensic accreditation;
STABILITY;
AMPHETAMINE;
SPECIMENS;
MORPHINE;
MS;
D O I:
10.1016/j.forsciint.2011.10.034
中图分类号:
DF [法律];
D9 [法律];
R [医药、卫生];
学科分类号:
0301 ;
10 ;
摘要:
LUCIO (R)-Direct-enzyme linked immunosorbent assay (ELISA) tests were validated for the screening of drugs of abuse cannabis, opiates, amphetamines and cocaine in urine for the new German medical and psychological assessment (MPA) guidelines with subsequent gas chromatographic-mass spectrometric (GC-MS) confirmation. The screening cut-offs corresponding to 10 ng/mL 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH), 50 ng/mL amphetamine, 25 ng/mL morphine and codeine and 30 ng/mL benzoylecgonine were chosen at the point where the number of false negatives was lower than 1%. Due to their accuracy, ease of use and rapid analysis, these ELISA tests are very promising for cases where a large proportion of the tests are expected to be negative such as for abstinence monitoring as part of the driving licence re-granting process. (C) 2011 Elsevier Ireland Ltd. All rights reserved.